Production (Stage)
bluebird bio, Inc.
BLUE
$4.98
-$0.02-0.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -29.07M | -28.71M | -60.81M | -81.39M | -69.80M |
| Total Depreciation and Amortization | 15.54M | 13.91M | 15.34M | 16.53M | 15.47M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.27M | 11.96M | 12.59M | 15.82M | 9.13M |
| Change in Net Operating Assets | -44.18M | -47.32M | -36.06M | -17.20M | -29.47M |
| Cash from Operations | -43.44M | -50.16M | -68.93M | -66.25M | -74.68M |
| Capital Expenditure | -859.00K | -485.00K | -280.00K | -59.00K | -1.78M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.96M | 2.95M | 746.00K | 1.68M | 1.12M |
| Cash from Investing | 3.10M | 2.47M | 466.00K | 1.62M | -655.00K |
| Total Debt Issued | -- | 0.00 | 0.00 | 0.00 | 71.32M |
| Total Debt Repaid | -28.02M | -16.37M | -20.93M | -26.44M | -22.21M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 54.73M | 51.36M | 14.83M | 20.37M | 15.54M |
| Cash from Financing | 26.71M | 34.99M | -6.11M | -6.06M | 64.65M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.63M | -12.71M | -74.57M | -70.69M | -10.69M |